Live Breaking News & Updates on Laurenz kellenberger

Stay informed with the latest breaking news from Laurenz kellenberger on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Laurenz kellenberger and stay connected to the pulse of your community

Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics

Allschwil, Switzerland, April 09, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal...

Allschwil , Switzerland-general- , Switzerland , Basilea , Basel-stadt , Germany , Swiss , Nils-schr , Laurenz-kellenberger , Head-of-corporate-communications-investor-relations , Biomedical-advanced-research , Administration-for-strategic-preparedness

Basilea Awarded CARB-X Grant To Develop Recently Acquired Novel Class Of Antibiotics

Basilea Awarded CARB-X Grant To Develop Recently Acquired Novel Class Of Antibiotics
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Basilea , Basel-stadt , Switzerland , Germany , Allschwil , Switzerland-general- , Swiss , Laurenz-kellenberger , Human-services , Germany-federal-ministry-of-education , Development-authority , Administration-for-strategic-preparedness

Genevant secures $114M deal with Tome to develop liver therapy

Genevant secures $114M deal with Tome to develop liver therapy
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Swiss , Laurenz-kellenberger , Pete-lutwyche , Basilea-pharmaceutica , Genevant-sciences , Novo-nordisk , World-health-organization , Tome-bioscience , Replace-therapeutics , Chief-scientific-officer-laurenz-kellenberger ,

Basilea Pharmaceutica AG: Basilea announces acquisition of preclinical antibiotics program from Spexis

Basilea Pharmaceutica AG: Basilea announces acquisition of preclinical antibiotics program from Spexis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Germany , Allschwil , Switzerland-general- , Switzerland , Basilea , Basel-stadt , Swiss , Laurenz-kellenberger , Canton-basel-landschaft , Nils-schr , World-health-organization , Swiss-exchange

Basilea To Buy Preclinical Antibiotics Program From Spexis

Basilea Pharmaceutica AG (BPMUF, 0QNA.L), a Swiss commercial-stage biopharmaceutical company, Monday announced its asset purchase agreement with Spexis AG to acquire a preclinical program of antibiotics for up to a total of 2 million Swiss francs.

Basilea , Basel-stadt , Switzerland , Swiss , Laurenz-kellenberger , Canton-basel-landschaft , World-health-organization , District-court , More-such-health-news , Basilea-pharmaceutica , Western-district-court , Chief-scientific-officer

Basilea Pharmaceutica AG: Basilea reports preliminary 2022 revenues, exceeding guidance, and provides portfolio update

Continued commercial success of Cresemba and Zevtera in 2022 generated revenue contributions of approx. CHF 122 million, exceeding guidance by more than 17%Significant proceeds from oncology transactionsFollowing

China , Japan , Basilea , Basel-stadt , Switzerland , United-states , Canada , Brazil , Swiss , Nils-schr , Basel-allschwil , Marc-engelhardt

Basilea reports preliminary 2022 revenues, exceeding guidance, and provides portfolio update

Basilea reports preliminary 2022 revenues, exceeding guidance, and provides portfolio update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , Japan , Basilea , Basel-stadt , Switzerland , United-states , Canada , Brazil , Swiss , Nils-schr , Basel-allschwil , Allschwil-hegenheimermattweg

Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center

Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , Basilea , Basel-stadt , Switzerland , Fox-chase , Swiss , Nils-schr , Laurenz-kellenberger , Pennsylvania-biotechnology-center , Pennsylvania-drug-discovery-institute , Us-office-of-the

Investegate |Basilea Pharmaceutica AG Announcements | Basilea Pharmaceutica AG: Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center

Investegate |Basilea Pharmaceutica AG Announcements | Basilea Pharmaceutica AG: Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , Basilea , Basel-stadt , Switzerland , Fox-chase , Swiss , Nils-schr , Laurenz-kellenberger , Pennsylvania-biotechnology-center , Head-of-corporate-communications-investor-relations , Pennsylvania-drug-discovery-institute

Basilea Pharmaceutica AG: Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center

Basel, Switzerland, April 27, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with bacterial and fungal infections

Pennsylvania , United-states , Basilea , Basel-stadt , Switzerland , Fox-chase , Swiss , Nils-schr , Laurenz-kellenberger , Pennsylvania-biotechnology-center , Head-of-corporate-communications-investor-relations , Pennsylvania-drug-discovery-institute